ITPKA suppresses glioma progression and predicts patient prognosis
Frontiers in Oncology · 22.04.2026 · 16
DOI: 10.3389/fonc.2026.1802857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 22.04.2026. Verfasst von Naiyue Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, the Second Affiliated Hospital of Wannan Medical College, Wuhu, China. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Inositol 1,4,5-trisphosphate 3-kinase A (ITPKA) is expressed in various tumors and is associated with tumor progression. This study investigated the expression patterns of ITPKA in gliomas and explored its functional role in glioblastoma (GBM), thereby providing new insights into the diagnostic and prognostic evaluations of ITPKA in this disease.
Methods
ITPKA expression levels in glioma tissues of different World Health Organization (WHO) grades and GBM cell lines were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR) and Western blotting. U251-MG and T98G cells were transfected with negative control, ITPKA overexpression or ITPKA knockdown plasmids, followed by relevant detections. Subsequently, the viability, proliferation, migration and invasion abilities, cell cycle progression, and apoptosis rate of GBM cells in each group were detected using the Cell-Counting Kit-8 (CCK-8), 5-ethynyl-2′-deoxyuridine (EdU) proliferation, wound healing, Transwell, and flow cytometry assays, respectively. Subsequently, the effect of ITPKA on GBM growth was evaluated in a nude mouse subcutaneous tumor xenograft model.
Results
Overexpression of ITPKA significantly inhibited the proliferation, migration, and invasion capabilities of GBM cells of the two GBM cell lines in vitro and the progression of subcutaneous xenograft tumors of two GBM cell lines in nude mice in vivo . In contrast, ITPKA knockdown significantly promoted the proliferation, migration, and invasion capabilities of GBM cells in the two GBM cell lines in vitro and the progression of subcutaneous xenograft tumors in these two GBM cell lines in nude mice.
Conclusions
Low expression of ITPKA in glioma tissues correlates with GBM progression, indicating that it may act as a tumor suppressor gene and is a candidate biomarker for the molecular diagnostic and prognostic evaluations of glioblastoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, the Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
- The Translational Research Institute for Neurological Disorders, Department of Neurosurgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China.
- The Institutes of Brain Science, Wannan Medical College, Wuhu, China.
Zitieren
APA
Zhang, N., Peng, M., Liu, J., & Ling, S. (2026). ITPKA suppresses glioma progression and predicts patient prognosis. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1802857
Vancouver
Zhang N, Peng M, Liu J, Ling S. ITPKA suppresses glioma progression and predicts patient prognosis. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1802857
BibTeX
@article{Zhang2026,
author = {Zhang, Naiyue and Peng, Min and Liu, Jun and Ling, Shizhang},
title = {ITPKA suppresses glioma progression and predicts patient prognosis},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1802857}
}
EUVIMED